PCSK9 price-cut matchup is on, as Regeneron and Sanofi slash Praluent list tag 60%
admin 11th February 2019 Uncategorised 0In a tit-for-tat pricing battle between two PCSK9 drugs, Regeneron and Sanofi are cutting the retail stickers on their cholesterol drug Praluent by 60%, matching the $5,850 level Amgen has reached with its so-far-better-selling rival Repatha.
More: PCSK9 price-cut matchup is on, as Regeneron and Sanofi slash Praluent list tag 60%
Source: fierce